Loading...
High triglyceride levels are common among HIV-infected patients receiving potent antiretroviral therapy (ART) and may increase their risk for coronary artery disease. Fish oil and fibrates have each been shown to reduce triglyceride levels in HIV-infected patients, but few comparative data are available.
To address this gap, ACTG investigators conducted a randomized trial among 100 HIV-infected patients receiving ART who, despite dietary interventions, had fasting serum triglyceride levels ≥400 mg/dL and LDL cholesterol levels ≤160 mg/dL. Patients were randomized to receive fish oil (3 g twice daily) or fenofibrate (160 mg once daily) for 8 weeks, at which point they were evaluated for response. Those who did not achieve triglyceride levels …